8/9/17 and some 10 Flashcards
Heme favor O2 relative to CO
Ligand constrained to bind in bent fashion, normal for O2 but not CO
CO only binds slightly better
Mb vs Hb
Mb a monomer, Hb a tetramer
Mb stores 02 while Hb transports it
O2 dissociation curves
Mb has higher oxygen affinity, reservoir for oxygen in skeletal muscles
Hb has sigmoidal curve that demonstrates cooperativity
T and R state
T is low oxygen
R is high oxygen
Proximal His
F8 from N terminus
His 87 each alpha helix
Oxygen binding
Fe2+ binds to proximal His and is above the plane of the ring
Oxygen pulls Fe2+ back into ring plane and moves the helix with the proximal His
Subunit interface interactions
Tetramer functions more so like a dimer of dimers
A1B1 = A2B2
A1A2
A1B2 = A2B1
B1B2
T state stabilization
A1B2 interface:
His B146 with Lys A40
A1A2:
His A122 with Asp A126
Allosteric Inhibitors of Hb
Shift dissoc curve right, more oxygen unloading in tissues
pH
Intracellular cons of 2,3-bisphosphoglycerate (BPG), binds to Beta subunits
CO2 binding to Hb
Bohr Effect
Effect of pH on Hb oxygen affinity
Only acid Bohr effect works
More acid means less oxygen bound
T state has greater affinity for protons than R state from His residues
Short term adjustment to high altitude
Up intra-erythrocytes conc. Of BPG
BPG comes from increased glycolytic activity
Role of inspire
Uncharged so pass into RBCs and converted to BPG to help increase the depleted levels
CO2 transport
Carbamoylation of the N terminal
Stabilizes T state over R
NOT by binding to heme
Carries CO2 from tissues to lungs, also does H+
Screening
Presumptive identification of unrecognized disease or condition by tests or other procedures
Perform on healthy people, not used for diagnostic
Types of disease prevention
Primary: prevent disease before it starts, before disease onset
Secondary: delay symptoms, onset to symptom appearance
Tertiary: slow disease progression, symptoms to death
Validity types
Internal: measure what supposed to
External: how well result generalize to rest of the population
Test sensitivity
Number of people who screen positive divided by the number of people actually with the disease
Optimize to prevent disease transmission
Test specificity
Number of peps who screen negative among those who actually don’t have the disease
Optimize for fatal disease with no treatment
Predictive values
Positive: peps with disease that tested positive divided by all positive tests
Negative: peps with disease that tested negative divided by all negative tests
miRNA
Regulate mRNA by degrade or inhibit translation if same or complementary to miRNA sequence